About Medvik Pharmaceuticals Private Limited
Data last updated:
Medvik Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 September 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2019PTC355065. Its GSTIN is 07AAMCM9412F1ZC (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nitin Khurana and Isha Khurana.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No 82/B 1st Floor Rishi Nagar Rani Bagh, Delhi, India – 110034.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.05 Cr, a growth of 78% compared to the previous year. For the same year it recorded a net profit of ₹33.55 Lakh (net margin 4.8%) and EBITDA of ₹46.38 Lakh (EBITDA margin 6.6%). Revenue has grown at a compounded annual rate (CAGR) of 88% over three years and 103% over five years.
Court records list 1 case involving the company, including 1 filed against it.
For more details, the company can be reached via its website medvikpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressHouse No 82/B 1st Floor Rishi Nagar Rani Bagh, Delhi, India – 110034
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Medvik Pharmaceuticals Private Limited
The main business activity of Medvik Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Medvik Pharmaceuticals Private Limited FY 2025 filings available
Medvik Pharmaceuticals Private Limited reported revenue of ₹7.05 Cr (up 78% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Medvik Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 103% over five years, including 78% growth in the latest year. EBITDA rose 91% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Medvik Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹46.38 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹33.55 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Medvik Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medvik Pharmaceuticals are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Medvik Pharmaceuticals Private Limited
Medvik Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aar Pee Life Care Private Limited | ₹7.08 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | Gharoli, Delhi, India |
| Ampira Biotechnics Private Limited | ₹7.07 Cr (FY 2024) | •••• | •••• | 5.0% | •••• | Manimajra, Chandigarh, India |
| Acumen Pharmaceuticals Private Limited | ₹7.07 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Madurai, Tamil Nadu, India |
| Gena Pharmaceuticals Limited | ₹7.07 Cr (FY 2020) | •••• | •••• | -30.0% | •••• | Kolkata, West Bengal, India |
| Taiki Pharmaceutical Private Limited | ₹7.06 Cr (FY 2025) | •••• | •••• | 218.0% | •••• | Roorkee, Uttarakhand, India |
| Medvik Pharmaceuticals Private Limited this company | ₹7.05 Cr (FY 2025) | •••• | •••• | 78.0% | •••• | Delhi, India |
| Siyona Designers Private Limited | ₹7.05 Cr (FY 2024) | •••• | •••• | 5.0% | •••• | Kolkata, West Bengal, India |
| Vivex Pharmaceuticals Private Limited | ₹7.05 Cr (FY 2024) | •••• | •••• | 51.0% | •••• | Mohali, Punjab, India |
| Qren Lifesciences Private Limited | ₹7.05 Cr (FY 2024) | •••• | •••• | 22.0% | •••• | Hyderabad, Telangana, India |
| Preegus Healthcare Private Limited | ₹7.04 Cr (FY 2024) | •••• | •••• | 31.0% | •••• | New Delhi, Delhi, India |
| Kinesis Pharmaceuticals Private Limited | ₹7.04 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Medvik Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Medvik Pharmaceuticals Private Limited
Medvik Pharmaceuticals Private Limited is audited by SUMIT CHOPRA for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SUMIT CHOPRA | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Medvik Pharmaceuticals Private Limited
Medvik Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nitin Khurana | Director | 13 Sep 2019 | 7 Years 0 Months | Current |
| Isha Khurana | Director | 13 Sep 2019 | 7 Years 0 Months | Current |
Ownership and Shareholding of Medvik Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Medvik Pharmaceuticals Private Limited
Medvik Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Medvik Pharmaceuticals Private Limited
Medvik Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed. Status as checked on 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ghaziabad, Uttar Pradesh | Criminal case | Filed against the company by State Government | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Medvik Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Medvik Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Medvik Pharmaceuticals Private Limited
Medvik Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Isha Khurana was appointed as Director on 13 Sep 2019.
Credit Ratings, Litigation & Regulatory Alerts for Medvik Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medvik Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medvik Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Medvik Pharmaceuticals Private Limited
Medvik Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAMCM9412F1ZC | Delhi | Active | 18 Sep 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medvik Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medvik Pharmaceuticals Private Limited
Medvik Pharmaceuticals is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 September 2019 (7+ years old) and is registered under CIN U51909DL2019PTC355065.
Medvik Pharmaceuticals reported revenue of ₹7.05 Cr for FY 2025 (up 78% YoY).
Medvik Pharmaceuticals has 2 current directors:
- Nitin Khurana - Director
- Isha Khurana - Director
Medvik Pharmaceuticals reported a net profit of ₹33.55 Lakh (net margin 4.8%) and EBITDA of ₹46.38 Lakh (EBITDA margin 6.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Medvik Pharmaceuticals is 88% over three years and 103% over five years. In the latest year (FY 2025) revenue rose 78%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Medvik Pharmaceuticals is 07AAMCM9412F1ZC, registered in Delhi.
The CIN (Corporate Identification Number) of Medvik Pharmaceuticals is U51909DL2019PTC355065. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medvik Pharmaceuticals has 1 court case on record: 1 filed against it.
Medvik Pharmaceuticals was incorporated on 13 September 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Medvik Pharmaceuticals by revenue are Aar Pee Life Care Private Limited, Ampira Biotechnics Private Limited, Acumen Pharmaceuticals Private Limited, Gena Pharmaceuticals Limited, Taiki Pharmaceutical Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Isha Khurana was appointed as Director on 13 Sep 2019. Nitin Khurana was appointed as Director on 13 Sep 2019.